In breast cancer, it has been shown that miR-210 in EVs released by cancer cells is delivered to endothelial cells through the neutral sphingomyelinase 2 (nSMase2)-regulated secretory machinery and contributes via enhanced angiogenesis [94]. Here, SMPD3 is linked to cancer.